BMEA

Biomea Fusion, Inc. (BMEA)

NASDAQ
$1,73
$+0,14
(+8,81%)
Market Closed
Biomea Fusion, Inc. (BMEA) Live Price Chart
Last updated: ⁦2026-08-25 21:16:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Key Market Data

$99,30M

$1,63

$43,69

$0,87

$1,59

$+0,14

+8,81%

4M

Biomea Fusion, Inc. (BMEA) Stock Price Today

Biomea Fusion, Inc. (BMEA) is currently trading at $1,73 as of 2026-08-25 21:16:00, reflecting a +8,81% move ($+0,14) from the previous close.

In the short term, the stock has returned +36,90% over the past four weeks. Over the last 12 months, Biomea Fusion, Inc. has recorded a -4,70% price change, indicating a Weak performance relative to the broader market.

Biomea Fusion, Inc. (BMEA) 7-Day Stock Price Changes

Over the past seven days, Biomea Fusion, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $1,38 to the latest recorded price of $1,73, reflecting an intraday change of +8,81%. Daily movements highlight shifts in trading volume (4 357 006), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, BMEA has delivered a +36,90% return over the past month and a -4,70% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Biomea Fusion, Inc. (BMEA)

You can buy and trade BMEA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for BMEA and Execute Your Trade
Step 3: Search for BMEA and Execute Your Trade
Open the trading page, enter BMEA in the search bar, select the amount of BMEA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Biomea Fusion, Inc. (BMEA)?

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Biomea Fusion, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
37
Sector
PHARMACEUTICAL PREPARATIONS
Company Website

Frequently Asked Questions (FAQ)

1.Can I buy and sell U.S. stocks directly on MEXC right now?
Yes. MEXC supports direct trading of U.S. stocks in three ways: RealStocks (held via a regulated broker partner), Tokenized Stocks that trade 24/7 with self-custody, and Stock Futures with up to 200x leverage. You can fund a purchase with local currency or crypto, and manage all three product types from a single account.
2.What type of U.S. stocks can I trade on MEXC?
You can trade thousands of leading U.S. equities listed on major exchanges like the NYSE and NASDAQ, including tech giants like Apple (AAPL), Tesla (TSLA), and NVIDIA (NVDA), as well as newly listed IPOs. Availability varies by product type — RealStocks, Tokenized Stocks, and Stock Futures each carry their own list of supported tickers.
3.Are stock prices and trading data updated in real-time?
Yes. MEXC provides real-time pricing, 24-hour fluctuations, and market cap rankings across all three stock products, so your buy and sell decisions are based on live data, not delayed quotes.
4.Can I trade U.S. stocks 24/7, or only during market hours?
It depends on the product. RealStocks follow standard U.S. market hours (9:30 AM–4:00 PM ET, Monday–Friday). Tokenized Stocks and Stock Futures trade continuously, 24/7, letting you act on price moves even when traditional markets are closed.
5.Does MEXC charge commission on U.S. stock trading?
RealStocks trade commission-free. Tokenized Stocks and Stock Futures carry a small trading fee, among the lowest in the industry — currently as low as 0.00%/0.02% maker/taker on Stock Futures.
6.What does BMEA's EPS tell investors about its profitability?
Trailing-twelve-month EPS of $ -0,45 summarises how much profit Biomea Fusion, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track Biomea Fusion, Inc.'s financial performance over time?
To follow Biomea Fusion, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how BMEA is performing and how the market is responding.
8.When is Biomea Fusion, Inc. expected to report earnings?
Biomea Fusion, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for BMEA, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in Biomea Fusion, Inc.'s earnings reports?
Biomea Fusion, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether BMEA is meeting, beating or missing expectations.
10.How can I stay informed about Biomea Fusion, Inc.'s results and guidance?
You can stay up to date on Biomea Fusion, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for BMEA on this page helps you see how new information is being reflected in the stock.
11.Does Biomea Fusion, Inc. pay a regular cash dividend to its shareholders?
Biomea Fusion, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor BMEA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for BMEA?
Based on the latest earnings data, BMEA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Biomea Fusion, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Biomea Fusion, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is Biomea Fusion, Inc.?
Biomea Fusion, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is BMEA valued in terms of P/E ratio and EPS?
Biomea Fusion, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0,45. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Biomea Fusion, Inc.'s earnings. Comparing BMEA's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MEXC Aug 8: Share $500K

MEXC Aug 8: Share $500KMEXC Aug 8: Share $500K

Refer friends early to earn 888% APR and $3,888

BMEA-to-USD Calculator

Amount

BMEA
BMEA
USD
USD

1 BMEA = 1,725 USD